Literature DB >> 9710209

Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells.

C Blaser1, M Kaufmann, C Müller, C Zimmermann, V Wells, L Mallucci, H Pircher.   

Abstract

We have used mRNA differential display PCR to search for genes induced in activated T cells and have found the LGALS1 (lectin, galactoside-binding, soluble) gene to be strongly up-regulated in effector T cells. The protein coded by the LGALS1 gene is a beta-galactoside-binding protein (betaGBP), which is released by cells as a monomeric negative growth factor but which can also associate into homodimers (galectin-1) with lectin properties. Northern blot analysis revealed that ex vivo isolated CD8+ effector T cells induced by a viral infection expressed high amounts of LGALS1 mRNA, whereas LGALS1 expression was almost absent in resting CD8+ T cells. LGALS1 expression could be induced in CD4+ and CD8+ T cells upon activation with the cognate peptide antigen and high levels of LGALS1 expression were found in concanavalin A-activated T cells but not in lipopolysaccharide-activated B cells. Gel filtration and Western blot analysis revealed that only monomeric betaGBP was released by activated CD8+ T cells and in vitro experiments further showed that recombinant betaGBP was able to inhibit antigen-induced proliferation of naive and antigen-experienced CD8+ T cells. Thus, these data indicate a role of betaGBP as an autocrine negative growth factor for CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710209     DOI: 10.1002/(SICI)1521-4141(199808)28:08<2311::AID-IMMU2311>3.0.CO;2-G

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  50 in total

Review 1.  Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses.

Authors:  Gabriel A Rabinovich; Marta A Toscano; Juan M Ilarregui; Natalia Rubinstein
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

2.  Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer.

Authors:  Dong Tang; Jun Gao; Sen Wang; Zhongxu Yuan; Nianyuan Ye; Yang Chong; Chuanqi Xu; Xuetong Jiang; Bin Li; Wei Yin; Yi Miao; Daorong Wang; Kuirong Jiang
Journal:  Tumour Biol       Date:  2015-03-01

Review 3.  The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders.

Authors:  J M Ilarregui; G A Bianco; M A Toscano; G A Rabinovich
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

Review 4.  Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomes.

Authors:  Zowi R Huinen; Elisabeth J M Huijbers; Judy R van Beijnum; Patrycja Nowak-Sliwinska; Arjan W Griffioen
Journal:  Nat Rev Clin Oncol       Date:  2021-04-08       Impact factor: 66.675

Review 5.  A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia.

Authors:  Sandra M Blois; Ralf Dechend; Gabriela Barrientos; Anne Cathrine Staff
Journal:  Cell Mol Life Sci       Date:  2014-09-06       Impact factor: 9.261

6.  The effects of galectin-1 on the gene expression of the transcription factors TBX21, GATA-3, FOXP3 and RORC.

Authors:  V D Yakushina; O A Vasil'eva; N V Ryazantseva; V V Novitsky; L A Tashireva
Journal:  Mol Cell Biochem       Date:  2014-10-09       Impact factor: 3.396

7.  Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function.

Authors:  Claudia C Motran; Karen M Molinder; Scot D Liu; Françoise Poirier; M Carrie Miceli
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

8.  Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes.

Authors:  Bettina Brandt; Tom Büchse; Ehab Fathi Abou-Eladab; Markus Tiedge; Eberhard Krause; Udo Jeschke; Hermann Walzel
Journal:  Histochem Cell Biol       Date:  2008-02-21       Impact factor: 4.304

9.  Induction of galectin-1 expression by HTLV-I Tax and its impact on HTLV-I infectivity.

Authors:  Sonia Gauthier; Isabelle Pelletier; Michel Ouellet; Amandine Vargas; Michel J Tremblay; Sachiko Sato; Benoit Barbeau
Journal:  Retrovirology       Date:  2008-11-25       Impact factor: 4.602

10.  Phosphoinositide 3-kinase targeting by the beta galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death.

Authors:  Valerie Wells; Livio Mallucci
Journal:  Breast Cancer Res       Date:  2009-01-08       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.